• Je něco špatně v tomto záznamu ?

Plasma C16-Cer levels are increased in patients with preterm labor

P. Laudanski, K. Charkiewicz, R. Kisielewski, P. Kuc, E. Koc-Zorawska, G. Raba, J. Kraczkowski, V. Dymicka-Piekarska, A. Chabowski, M. Kacerovsky, B. Jacobsson, P. Zabielski, A. Blachnio-Zabielska,

. 2016 ; 123 (-) : 40-5. [pub] 20160513

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023981

INTRODUCTION: The pathogenesis of preterm labor is fragmentarily explained. The most widely accepted theory points out to infection and inflammation as possible causes, which can be mediated by potentially different factors, including sphingolipid mediators. Sphingolipids are a class of lipids that have been shown as important mediators in various cell processes such as: proliferation, growth, apoptosis, stress response, necrosis and inflammation. The aim of the study was to assess plasma concentrations of selected sphingolipids in patients with preterm labor. MATERIAL AND METHODS: We used ultra-high performance liquid chromatography with triple mass spectrometry (UHPLC-ESI-MS/MS) to assess plasma concentrations of the 11 sphingolipids in patients presenting with symptoms of preterm labor (n=61) and threatened preterm labor (n=40). RESULTS: We observed a statistically significant increase (p-value<0.004) in plasma concentrations of C16-Cer in patients with preterm labor as compared to the control group. We also found C16-Cer to be the best predictor of preterm labor in the group of patients with symptoms occurring after 32 weeks of gestation. CONCLUSIONS: Our findings show a possible involvement of selected sphingolipids, especially C16-Cer, in the pathogenesis of preterm labor. Their role as predictors of preterm delivery needs to be validated in the future on larger group of patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023981
003      
CZ-PrNML
005      
20170908124610.0
007      
ta
008      
170720s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.prostaglandins.2016.04.005 $2 doi
035    __
$a (PubMed)27184754
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Laudanski, Piotr $u Department of Perinatology, Medical University of Bialystok, ul. Marii Sklodowskiej-Curie 24a, 15-276 Bialystok, Poland. Electronic address: plauda@umb.edu.pl.
245    10
$a Plasma C16-Cer levels are increased in patients with preterm labor / $c P. Laudanski, K. Charkiewicz, R. Kisielewski, P. Kuc, E. Koc-Zorawska, G. Raba, J. Kraczkowski, V. Dymicka-Piekarska, A. Chabowski, M. Kacerovsky, B. Jacobsson, P. Zabielski, A. Blachnio-Zabielska,
520    9_
$a INTRODUCTION: The pathogenesis of preterm labor is fragmentarily explained. The most widely accepted theory points out to infection and inflammation as possible causes, which can be mediated by potentially different factors, including sphingolipid mediators. Sphingolipids are a class of lipids that have been shown as important mediators in various cell processes such as: proliferation, growth, apoptosis, stress response, necrosis and inflammation. The aim of the study was to assess plasma concentrations of selected sphingolipids in patients with preterm labor. MATERIAL AND METHODS: We used ultra-high performance liquid chromatography with triple mass spectrometry (UHPLC-ESI-MS/MS) to assess plasma concentrations of the 11 sphingolipids in patients presenting with symptoms of preterm labor (n=61) and threatened preterm labor (n=40). RESULTS: We observed a statistically significant increase (p-value<0.004) in plasma concentrations of C16-Cer in patients with preterm labor as compared to the control group. We also found C16-Cer to be the best predictor of preterm labor in the group of patients with symptoms occurring after 32 weeks of gestation. CONCLUSIONS: Our findings show a possible involvement of selected sphingolipids, especially C16-Cer, in the pathogenesis of preterm labor. Their role as predictors of preterm delivery needs to be validated in the future on larger group of patients.
650    _2
$a dospělí $7 D000328
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a ceramidy $x krev $7 D002518
650    _2
$a vysokoúčinná kapalinová chromatografie $7 D002851
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a gestační stáří $7 D005865
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec nedonošený $7 D007234
650    _2
$a předčasná porodní činnost $x krev $x diagnóza $x patofyziologie $7 D007752
650    _2
$a těhotenství $7 D011247
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a tandemová hmotnostní spektrometrie $7 D053719
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Charkiewicz, Karol $u Department of Perinatology, Medical University of Bialystok, ul. Marii Sklodowskiej-Curie 24a, 15-276 Bialystok, Poland.
700    1_
$a Kisielewski, Rafal $u Department of Gynecologic Oncology, Oncology Center in Bialystok, ul. Ogrodowa 12, 15-057 Bialystok, Poland.
700    1_
$a Kuc, Pawel $u Department of Perinatology, Medical University of Bialystok, ul. Marii Sklodowskiej-Curie 24a, 15-276 Bialystok, Poland.
700    1_
$a Koc-Zorawska, Ewa $u Department of Nephrology with Dialysis Centre, Medical University of Bialystok, ul. Zurawia 14, 15-540 Bialystok, Poland.
700    1_
$a Raba, Grzegorz $u Institute of Obstetric and Emergency Medicine, University of Rzeszow, 37-710 Zurawica, Poland.
700    1_
$a Kraczkowski, Janusz $u Department of Obstetrics and Pathology of Pregnancy, Medical University of Lublin, 20-081 Lublin, Poland.
700    1_
$a Dymicka-Piekarska, Violetta $u Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, J. Waszyngtona 15A, 15-269 Bialystok, Poland.
700    1_
$a Chabowski, Adrian $u Department of Physiology, Medical University of Bialystok, ul. Mickiewicza 2C, 15-222 Bialystok, Poland.
700    1_
$a Kacerovsky, Marian $u Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Jacobsson, Bo $u Department of Obstetrics and Gynecology, Institute for the Health of Women and Children, Sahlgrenska University Hospital, Göteborg, Sweden; Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway.
700    1_
$a Zabielski, Piotr $u Department of Physiology, Medical University of Bialystok, ul. Mickiewicza 2C, 15-222 Bialystok, Poland.
700    1_
$a Blachnio-Zabielska, Agnieszka $u Department of Physiology, Medical University of Bialystok, ul. Mickiewicza 2C, 15-222 Bialystok, Poland.
773    0_
$w MED00005018 $t Prostaglandins & other lipid mediators $x 1098-8823 $g Roč. 123, č. - (2016), s. 40-5
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27184754 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170908125211 $b ABA008
999    __
$a ok $b bmc $g 1239662 $s 984894
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 123 $c - $d 40-5 $e 20160513 $i 1098-8823 $m Prostaglandins & other lipid mediators $n Prostaglandins Other Lipid Mediat $x MED00005018
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...